Calibrium's Acquisition

Calibrium was acquired by Novo Nordisk on August 27, 2015.

Calibrium is an emerging privately held biopharmaceutical company focused on developing a portfolio of novel drug candidates for the treatment of diabetes and related metabolic diseases.…

Articles about Calibrium's Acquisition: